INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $980,000 | -60.0% | 196,351 | -42.7% | 0.18% | -25.8% |
| Q3 2021 | $2,452,000 | +123.7% | 342,414 | +189.5% | 0.24% | +53.2% |
| Q2 2021 | $1,096,000 | -63.4% | 118,270 | -65.1% | 0.15% | -77.6% |
| Q1 2021 | $2,997,000 | 0.0% | 338,601 | 0.0% | 0.69% | +1.0% |
| Q4 2020 | $2,997,000 | +1186.3% | 338,601 | +1587.8% | 0.68% | +1264.0% |
| Q3 2020 | $233,000 | – | 20,062 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |